BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Klumpp L, Sezgin EC, Skardelly M, Eckert F, Huber SM. KCa3.1 Channels and Glioblastoma: In Vitro Studies. Curr Neuropharmacol 2018;16:627-35. [PMID: 28786347 DOI: 10.2174/1570159X15666170808115821] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen PY, Li XD, Ma WN, Li H, Li MM, Yang XY, Li SY. Comprehensive Transcriptomic Analysis and Experimental Validation Identify lncRNA HOXA-AS2/miR-184/COL6A2 as the Critical ceRNA Regulation Involved in Low-Grade Glioma Recurrence. Onco Targets Ther 2020;13:4999-5016. [PMID: 32581558 DOI: 10.2147/OTT.S245896] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
2 Tiffner A, Hopl V, Schober R, Sallinger M, Grabmayr H, Höglinger C, Fahrner M, Lunz V, Maltan L, Frischauf I, Krivic D, Bhardwaj R, Schindl R, Hediger MA, Derler I. Orai1 Boosts SK3 Channel Activation. Cancers (Basel) 2021;13:6357. [PMID: 34944977 DOI: 10.3390/cancers13246357] [Reference Citation Analysis]
3 Zirjacks L, Stransky N, Klumpp L, Prause L, Eckert F, Zips D, Schleicher S, Handgretinger R, Huber SM, Ganser K. Repurposing Disulfiram for Targeting of Glioblastoma Stem Cells: An In Vitro Study. Biomolecules 2021;11:1561. [PMID: 34827559 DOI: 10.3390/biom11111561] [Reference Citation Analysis]
4 Brandalise F, Ratto D, Leone R, Olivero F, Roda E, Locatelli CA, Grazia Bottone M, Rossi P. Deeper and Deeper on the Role of BK and Kir4.1 Channels in Glioblastoma Invasiveness: A Novel Summative Mechanism? Front Neurosci 2020;14:595664. [PMID: 33328867 DOI: 10.3389/fnins.2020.595664] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Mokrane N, Snabi Y, Cens T, Guiramand J, Charnet P, Bertaud A, Menard C, Rousset M, de Jesus Ferreira MC, Thibaud JB, Cohen-Solal C, Vignes M, Roussel J. Manipulations of Glutathione Metabolism Modulate IP3-Mediated Store-Operated Ca2+ Entry on Astroglioma Cell Line. Front Aging Neurosci 2021;13:785727. [PMID: 34975458 DOI: 10.3389/fnagi.2021.785727] [Reference Citation Analysis]
6 Pethő Z, Najder K, Carvalho T, McMorrow R, Todesca LM, Rugi M, Bulk E, Chan A, Löwik CWGM, Reshkin SJ, Schwab A. pH-Channeling in Cancer: How pH-Dependence of Cation Channels Shapes Cancer Pathophysiology. Cancers (Basel) 2020;12:E2484. [PMID: 32887220 DOI: 10.3390/cancers12092484] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
7 Eckert F, Zwirner K, Boeke S, Thorwarth D, Zips D, Huber SM. Rationale for Combining Radiotherapy and Immune Checkpoint Inhibition for Patients With Hypoxic Tumors. Front Immunol 2019;10:407. [PMID: 30930892 DOI: 10.3389/fimmu.2019.00407] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
8 Maltan L, Andova A, Derler I. The Role of Lipids in CRAC Channel Function. Biomolecules 2022;12:352. [DOI: 10.3390/biom12030352] [Reference Citation Analysis]
9 Ren Q, Wang ZZ, Chu SF, Xia CY, Chen NH. Gap junction channels as potential targets for the treatment of major depressive disorder. Psychopharmacology (Berl) 2018;235:1-12. [PMID: 29178009 DOI: 10.1007/s00213-017-4782-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
10 Neuhaus E, Zirjacks L, Ganser K, Klumpp L, Schüler U, Zips D, Eckert F, Huber SM. Alternating Electric Fields (TTFields) Activate Cav1.2 Channels in Human Glioblastoma Cells. Cancers (Basel) 2019;11:E110. [PMID: 30669316 DOI: 10.3390/cancers11010110] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
11 Alharbi A, Zhang Y, Parrington J. Deciphering the Role of Ca2+ Signalling in Cancer Metastasis: From the Bench to the Bedside. Cancers (Basel) 2021;13:E179. [PMID: 33430230 DOI: 10.3390/cancers13020179] [Reference Citation Analysis]
12 Catacuzzeno L, Franciolini F. Role of KCa3.1 Channels in Modulating Ca2+ Oscillations during Glioblastoma Cell Migration and Invasion. Int J Mol Sci 2018;19:E2970. [PMID: 30274242 DOI: 10.3390/ijms19102970] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
13 Li X, Liu Y, Cao A, Li C, Wang L, Wu Q, Li X, Lv X, Zhu J, Chun H, Laba C, Du X, Zhang Y, Yang H. Crocin Improves Endothelial Mitochondrial Dysfunction via GPx1/ROS/KCa3.1 Signal Axis in Diabetes. Front Cell Dev Biol 2021;9:651434. [PMID: 33777959 DOI: 10.3389/fcell.2021.651434] [Reference Citation Analysis]
14 Ferrera L, Barbieri R, Picco C, Zuccolini P, Remigante A, Bertelli S, Fumagalli MR, Zifarelli G, La Porta CAM, Gavazzo P, Pusch M. TRPM2 Oxidation Activates Two Distinct Potassium Channels in Melanoma Cells through Intracellular Calcium Increase. IJMS 2021;22:8359. [DOI: 10.3390/ijms22168359] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Eckert F, Schilbach K, Klumpp L, Bardoscia L, Sezgin EC, Schwab M, Zips D, Huber SM. Potential Role of CXCR4 Targeting in the Context of Radiotherapy and Immunotherapy of Cancer. Front Immunol. 2018;9:3018. [PMID: 30622535 DOI: 10.3389/fimmu.2018.03018] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 14.0] [Reference Citation Analysis]
16 Palme D, Misovic M, Ganser K, Klumpp L, Salih HR, Zips D, Huber SM. hERG K+ Channels Promote Survival of Irradiated Leukemia Cells. Front Pharmacol 2020;11:489. [PMID: 32390841 DOI: 10.3389/fphar.2020.00489] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
17 Djamgoz MBA. Combinatorial Therapy of Cancer: Possible Advantages of Involving Modulators of Ionic Mechanisms. Cancers (Basel) 2022;14:2703. [PMID: 35681682 DOI: 10.3390/cancers14112703] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Mohr CJ, Steudel FA, Gross D, Ruth P, Lo WY, Hoppe R, Schroth W, Brauch H, Huber SM, Lukowski R. Cancer-Associated Intermediate Conductance Ca2+-Activated K⁺ Channel KCa3.1. Cancers (Basel) 2019;11:E109. [PMID: 30658505 DOI: 10.3390/cancers11010109] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
19 Ganser K, Klumpp L, Bischof H, Lukowski R, Eckert F, Huber SM. Potassium Channels in Cancer. Handb Exp Pharmacol 2021. [PMID: 33864122 DOI: 10.1007/164_2021_465] [Reference Citation Analysis]
20 Chen S, Wang C, Su X, Dai X, Li S, Mo Z. KCNN4 is a potential prognostic marker and critical factor affecting the immune status of the tumor microenvironment in kidney renal clear cell carcinoma. Transl Androl Urol 2021;10:2454-70. [PMID: 34295732 DOI: 10.21037/tau-21-332] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Mohr CJ, Gross D, Sezgin EC, Steudel FA, Ruth P, Huber SM, Lukowski R. KCa3.1 Channels Confer Radioresistance to Breast Cancer Cells. Cancers (Basel) 2019;11:E1285. [PMID: 31480522 DOI: 10.3390/cancers11091285] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
22 Hofschröer V, Najder K, Rugi M, Bouazzi R, Cozzolino M, Arcangeli A, Panyi G, Schwab A. Ion Channels Orchestrate Pancreatic Ductal Adenocarcinoma Progression and Therapy. Front Pharmacol 2020;11:586599. [PMID: 33841132 DOI: 10.3389/fphar.2020.586599] [Cited by in F6Publishing: 1] [Reference Citation Analysis]